TGF-β signaling seems to be less of a requirement for the suppression of Th1 and Th17 cell-mediated inflammation and its facilitation of tumor growth through increasing tumor-derived Nrp-1+ Treg cells. This evidence concerns the gene NRP1 and neoplasm.